Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Anticancer Research|October 3, 2018
Panobinostat and Nelfinavir Inhibit Renal Cancer Growth by Inducing Endoplasmic Reticulum StressKazuki Okubo, Makoto Isono, Takako Asano, et al.
Anticancer Research|November 10, 2019
Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer CellsKazuki Okubo, Makoto Isono, Takako Asano, et al.
Plos One|April 12, 2022
Ataxia telangiectasia and Rad3-related inhibition by AZD6738 enhances gemcitabine-induced cytotoxic effects in bladder cancer cellsMakoto Isono, Kazuki Okubo, Takako Asano, et al.
Scientific Reports|May 14, 2021
Inhibition of checkpoint kinase 1 potentiates anticancer activity of gemcitabine in bladder cancer cellsMakoto Isono, Kazuki Okubo, Takako Asano, et al.
Urology Case Reports|July 14, 2018
Recurrent retroperitoneal soft tissue sarcoma showing drastic reduction after pazopanib administration accompanied by severe liver dysfunctionKazuki Okubo, Akio Horiguchi, Keiichi Ito, et al.
Translational Oncology|March 9, 2019
Metformin Augments Panobinostat's Anti-Bladder Cancer Activity by Activating AMP-Activated Protein KinaseKazuki Okubo, Makoto Isono, Takako Asano, et al.
Translational Oncology|June 18, 2021
Simvastatin-romidepsin combination kills bladder cancer cells synergisticallyKazuki Okubo, Kosuke Miyai, Kimi Kato, et al.
Anticancer Research|October 3, 2018
Evaluation of Therapeutic Potential of Phenoxodiol, a Novel Isoflavone Analog, in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
Anticancer Research|June 1, 2018
Delanzomib Interacts with Ritonavir Synergistically to Cause Endoplasmic Reticulum Stress in Renal Cancer CellsMakoto Isono, Akinori Sato, Takako Asano, et al.
Oncology Research|October 8, 2016
Ritonavir Interacts With Belinostat to Cause Endoplasmic Reticulum Stress and Histone Acetylation in Renal Cancer CellsMakoto Isono, Akinori Sato, Kazuki Okubo, et al.
Pageof 3